Entecavir is indicated for the treatment of CHB in adults with compensated liver disease and evidence of active viral replication and either elevated ALT/aspartate aminotransferase (AST ...

Lamivudine Entecavir Adefovir D There is positive evidence of human fetal risk based on adverse-reaction data from investigational or marketing experience or studies in humans, but potential ...

The company’s lead program, DST-1308, is a long-acting injectable formulation of entecavir, an antiviral agent used in the treatment of chronic hepatitis B. By utilizing the Silica Matrix technology, ...

Bristol-Myers Squibb was founded in 1858 and has grown to be one of today's leading global pharmaceutical companies. For over 150 years, Bristol-Myers Squibb (BMS) has been committed to "discover ...

† Key Laboratory of Drug Targeting and Drug Delivery Systems, Ministry of Education, Sichuan University, Sichuan, People’s Republic of China ‡ Faculty of Life Sciences, The University of Manchester, ...